sulfasalazine has been researched along with Carcinoma, Small Cell in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, J | 1 |
| Lo, M | 1 |
| Dockery, P | 1 |
| Mahon, S | 1 |
| Karp, CM | 1 |
| Buckley, AR | 1 |
| Lam, S | 1 |
| Gout, PW | 1 |
| Wang, YZ | 1 |
| Awasthi, S | 1 |
| Sharma, R | 1 |
| Singhal, SS | 1 |
| Herzog, NK | 1 |
| Chaubey, M | 1 |
| Awasthi, YC | 1 |
2 other studies available for sulfasalazine and Carcinoma, Small Cell
| Article | Year |
|---|---|
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Topics: Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transpo | 2009 |
Modulation of cisplatin cytotoxicity by sulphasalazine.
Topics: Carcinoma, Small Cell; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; | 1994 |